IRIS
FERRARO, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.090
NA - Nord America 1.564
EU - Europa 1.469
SA - Sud America 197
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 57
OC - Oceania 1
Totale 5.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.473
SG - Singapore 818
IT - Italia 547
RU - Federazione Russa 522
VN - Vietnam 466
CN - Cina 403
BR - Brasile 158
HK - Hong Kong 143
DE - Germania 108
FR - Francia 80
BD - Bangladesh 68
CA - Canada 55
JP - Giappone 45
GB - Regno Unito 41
NL - Olanda 40
IN - India 39
FI - Finlandia 37
KR - Corea 33
MX - Messico 21
AR - Argentina 20
ES - Italia 18
UA - Ucraina 15
ZA - Sudafrica 15
AT - Austria 14
PH - Filippine 14
CI - Costa d'Avorio 11
PL - Polonia 10
SE - Svezia 10
EG - Egitto 6
IQ - Iraq 6
MA - Marocco 6
TW - Taiwan 6
EC - Ecuador 5
ID - Indonesia 5
JO - Giordania 5
PK - Pakistan 5
TH - Thailandia 5
VE - Venezuela 5
CY - Cipro 4
IE - Irlanda 4
LT - Lituania 4
RO - Romania 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BG - Bulgaria 3
KE - Kenya 3
LB - Libano 3
MY - Malesia 3
TR - Turchia 3
BJ - Benin 2
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
SA - Arabia Saudita 2
UY - Uruguay 2
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
CM - Camerun 1
CO - Colombia 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HT - Haiti 1
IL - Israele 1
IR - Iran 1
LC - Santa Lucia 1
MQ - Martinica 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RE - Reunion 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 5.380
Salva come PNG Salva come JPEG
Città #
Singapore 397
San Jose 278
Naples 177
Ashburn 167
Moscow 140
Hong Kong 136
Ho Chi Minh City 130
Hefei 120
Beijing 119
Hanoi 115
Chandler 95
Council Bluffs 89
Santa Clara 63
Lauterbourg 46
Los Angeles 45
Tokyo 41
Dong Ket 40
New York 33
Dallas 31
Rome 30
The Dalles 28
Milan 26
Redondo Beach 24
Munich 23
Amsterdam 22
Seoul 22
Düsseldorf 20
Napoli 20
Ottawa 19
Da Nang 18
Lawrence 18
Millbury 18
Frankfurt am Main 17
Boston 16
Buffalo 15
Lappeenranta 15
Salerno 15
Des Moines 14
São Paulo 14
Kochi 13
Falkenstein 12
Helsinki 12
Mexico City 12
Mugnano di Napoli 12
Cava de' Tirreni 11
Chicago 11
Montreal 11
Catania 10
Denver 10
Manchester 10
Nuremberg 10
Toronto 10
Turku 10
Atlanta 9
Bến Tre 9
Portsmouth 9
Charlotte 8
Florence 8
Phoenix 8
Seattle 8
Vienna 8
Can Tho 7
Haiphong 7
Houston 7
Orem 7
Shanghai 7
Stockholm 7
Dhaka 6
Nanjing 6
Wilmington 6
Aversa 5
Changsha 5
Chennai 5
Fisciano 5
Granada 5
Madrid 5
Ninh Bình 5
Pisa 5
Recife 5
Torre Annunziata 5
Turin 5
Wroclaw 5
Amman 4
Bari 4
Brooklyn 4
Bắc Giang 4
Dublin 4
Fairfield 4
Johannesburg 4
Kronberg 4
Limassol 4
Memphis 4
Miami 4
Pavia 4
Philadelphia 4
Portici 4
Rio de Janeiro 4
Roubaix 4
Sant'Antimo 4
Selargius 4
Totale 3.069
Salva come PNG Salva come JPEG
Nome #
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 166
Promelanogenic Effects by an Annurca Apple-Based Natural Formulation in Human Primary Melanocytes 159
IL-17-induced inflammation modulates the mPGES-1/PPAR-gamma pathway in monocytes/macrophages 155
Breast cancer chemotherapeutic options: a general overview on the preclinical validation of a multi-target ruthenium(III) complex lodged in nucleolipid nanosystems 154
Anticancer activity of a cationic Ru-based nanosystem in a human xenograft model of breast cancer 150
Induction of hair keratins expression by an Annurca Apple-based nutraceutical formulation in human follicular cells 149
Tuning Peptide-Based Nanofibers for Achieving Selective Doxorubicin Delivery in Triple-Negative Breast Cancer 148
Temporin L-derived peptide as a regulator of the acute inflammatory response in zymosan-induced peritonitis 147
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 144
Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders 142
Preclinical validation of an original Ru(III)-based nanosystem in human models of breast cancer 141
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 139
Supplementation with ribonucleotide-based ingredient (Ribodiet®) lessens oxidative stress, brain inflammation, and amyloid pathology in a murine model of Alzheimer 135
Lipophilicity profiling and cell viability assessment of a selected panel of endocrine disruptors 133
Exploring cellular uptake, accumulation and mechanism of action of an anticancer Ru(III) complex loaded into a nucleolipidic-based nanosystem in preclinical models of human breast cancer 130
Chemical characterization of wheat-based waste derived from a pharmaceutical process for its potential valorization 128
Preclinical evaluation of Tanshinones from Salvia miltiorrhiza Bunge on human glioblastoma models in vitro 128
Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy 127
Tetrasubstituted Pyrrole Derivative Mimetics of Protein–Protein Interaction Hot-Spot Residues: A Promising Class of Anticancer Agents Targeting Melanoma Cells 126
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 125
Nucleolipidic-based Ru(III) nanosystems induce multiple cell death pathways activation in preclinical models of human breast cancer 125
The combined use of biological investigations, bio chromatographic and in silico methods to solve the puzzle of badge and its derivative's toxicity 124
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders 122
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis 120
Enduring Neurobiological Consequences of Early-Life Stress: Insights from Rodent Behavioral Paradigms 120
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(III) complex with superior anticancer bioactivity 117
Antiviral activity of Taurisolo® during bovine alphaherpesvirus 1 infection 116
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 116
Design, Synthesis, and Anticancer Activity of Drug-like Iron Chelators/G-Quadruplex Binders as Synergic Dual Targeting Agents 113
The role of micrornas in development of colitis-associated colorectal cancer 111
Insight into Iron, Oxidative Stress and Ferroptosis: Therapy Targets for Approaching Anticancer Strategies 109
Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders 107
Prolonged activity of a recombinant manganese superoxide dismutase through a formulation of polymeric multi-layer nanoassemblies targeting cancer cells 104
Fatty Acid Synthase as Interacting Anticancer Target of the Terpenoid Myrianthic Acid Disclosed by MS-Based Proteomics Approaches 103
Bovine herpesvirus-1 infection in mouse neuroblastoma (Neuro-2A) cells 102
Coupling Interrupted Fischer and Multicomponent Joullié-Ugi to Chase Chemical Diversity: from Batch to Sustainable Flow Synthesis of Peptidomimetics 102
Furazanopyrazine-based novel promising anticancer agents interfering with the eicosanoid biosynthesis pathways by dual mPGES-1 and sEH inhibition 87
A new biocompatible butyric acid-releasing glucosamine derivative for transdermal delivery 86
Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer 77
5-methyl-2-carboxamidepyrrole-based novel dual mPGES-1/sEH inhibitors as promising anticancer candidates 77
MG-132 interferes with iron cellular homeostasis and alters virulence of bovine herpesvirus 1 75
Shielding siRNA by peptide-based nanofibers: An efficient approach for turning off EGFR gene in breast cancer 65
MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction 59
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 59
Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9 58
Overview of current detection methods and microRNA potential in Clostridioides difficile infection screening 57
Valorization of Arbutus unedo L. Pomace: Exploring the Recovery of Bioactive Phenolic Compounds from Distillation By-Products 48
Valorization of Citrus industry by-products through supercritical CO₂ extraction of natural compounds 40
Design and evaluation of dual-functional aptamer-peptide conjugates as a platform for targeted cancer therapy 30
Upcycling lemon peel waste into sustainable bioactive ingredients: chemical characterization and efficacy assessment 22
Involvement of serotonin receptor 7 in synaptic dysfunctions in a mouse model of autism spectrum disorder 14
Formyl peptide receptor 2 activation by MR-39 inhibits glioblastoma cell proliferation and invasiveness through suppression of multiple oncogenic pathways 9
Totale 5.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.150
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022124 0 0 6 1 5 7 4 2 10 18 26 45
2022/2023269 21 21 9 8 35 23 13 37 54 21 18 9
2023/2024204 10 22 34 18 13 16 15 23 5 11 16 21
2024/20251.371 61 58 13 37 24 87 164 87 95 151 442 152
2025/20263.093 256 194 318 284 563 114 297 187 386 204 160 130
2026/2027245 98 143 4 0 0 0 0 0 0 0 0 0
Totale 5.500